Table 1.
Age, ave. ± SD (min-max) | 64.0 ± 12.2 (42–88) | |
| ||
Age, n (%) | <50-year-old | 7 (14.0) |
50-70-year-old | 26 (52.0) | |
>70-year-old | 17 (34.0) | |
| ||
Gender, n (%) | Male | 34 (68.0) |
Female | 16 (32.0) | |
| ||
Operation, n (%) | R0 resection | 44 (88.0) |
Subtotal gastrectomy | 24 (48.0) | |
Total gastrectomy | 20 (40.0) | |
Palliative | 6 (12.0) | |
| ||
Pathology, n (%) | Adenocancer | 50 (100) |
| ||
Tumor A, ave. ± SD (min-max) | 34.1 ± 6.7 (21–47) | |
| ||
Clinical T, n (%) | 3 | 40 (80.0) |
4 | 10 (20.0) | |
| ||
Clinical N, n (%) | Positive | 19 (38.0) |
| ||
Clinical stage, n (%) | 2 | 30 (60.0) |
3 | 20 (40.0) | |
| ||
Pathological N, ave. ± SD (min-max) | 7.5 ± 5.4 (1–18) | |
| ||
Total lymph node, ave. ± SD (min-max) | 15.4 ± 6.2 (0–24) | |
| ||
Pathological stage, n (%) | 2B | 7 (14.0) |
3A | 12 (24.0) | |
3B | 14 (28.0) | |
3C | 11 (22.0) | |
4 | 6 (12.0) | |
| ||
Wound infection, n (%) | 9 (18.0) | |
Anastomose leak, n (%) | 9 (18.0) | |
Ileus, n (%) | 4 (8.0) | |
Atelectasis, n (%) | 4 (8.0) | |
Mortality, n (%) | 14 (28.0) |